Inhibitor Library

The following is a list of materials currently in the BioRx library. You may order any of the books, brochures, booklets, videos or DVD’s through our main office free of charge. Call 1-866-442-4679 or click here to order. If you’re looking for something that is not on our list, contact us and we’ll do our best to find it for you.

Inhibitor Related Books/Brochures

Inhibitors in Hemophilia: Current Perspectives and Future Direction; National Hemophilia Foundation, 2001

Your Guide to Factor VIII and Factor IX Inhibitors;
Novo Nordisk Pharmaceuticals, Inc., 2003 (brochure)

The Great Inhibinator by Chris Perretti Barnes, Illustrations by Michael Graham; Produced by BioRx and Bayer Healthcare, 2006 (children’s book, ages 3-15)

Inhibitor Related Articles

1. How Do You Know If You Have an Inhibitor?
   Reprinted from the NHF website
2. Inhibitors in Hemophilia: A Primer
   by Donna M. DiMichele, MD
   Reprinted from "NHF Community Alert"
   vol. 2, no. 1, February, 1995
3. Inhibitors: Just Another Hurdle on the Road to Living with Hemophilia
   Questions and Answer Sheet
   Answers provided by Dr. Indira Warrier, a Pediatric Hematologist at Children’s Hospital of Michigan, Detroit
   Reprinted from Belonging, Winter 2001
4. The Inhibitor Challenge
   by Lisette Hilton
   Reprinted from Hemaware, May/June, 2005
5. Road Block
   by Natalie Smith, MSN, AN, CNP
   Reprinted from Hemaware, January/February, 2004
6. Blood Coagulation & Fibrinolysis: Role of vonWillebrand Factor in Immune Tolerance Induction
   by Carmen Escuriola Ettingshausen and Wolfhart Kreuz
   Reprinted from Lippincott Williams & Wilkins, Vol. 16, April, 2005
7. Influence of vonWillebrand Factor on the Reactivity of Human Factor VIII Inhibitors with Factor VIII
   By M. Gensana, C. Altisent
   Reprinted from Haemophilia 2001, vol. 7
8. Treatment of Hereditary Angioedema with a Vapor-Heated C1 Inhibitor Concentrate
   By A. Thomas Waytes, M.D., PH.D., Fred Rosen, M.D., and Michael M. Frank, M.D.
   Reprinted from The New England Journal of Medicine; June 20, 1996
9. Immune Tolerance in Haemophilia-Principal Results from the International Registry: Report of the Factor VIII and IX Subcommittee
   by G. Mariani, A. Ghirardini, and R. Bellocco
   Reprinted from Thrombosis and Haemostasis: Journal of International Society on Thrombosis and Haemostasis; Vol. 72, No. 1, July 1994
10. Comparison of High Responder Inhibitor Frequency in Recent Studies of Previously Untreated Patients with Hemophilia A
    by Hartmut J. Ehrlich, Gordon L. Bray, and Edward D. Gomperts
    From Baxter Healthcare Corp., BioTech Europe, Unterschleissheim, Germany, and Hyland Division, Glendale, CA, USA
    Reprinted from Thrombosis and Haemostastis: Journal of the International Society of Thrombosis and Haemostasis; Vol 79, No. 1, January 1998
11. German Recommendations for Immune Tolerance Therapy in Type A Haemophiliacs with Antibodies
    by H.H. Brackmann, H. Lenk, I. Scharrer, G. Auerswald and W. Kreuz
    Reprinted from Haemophilia (1999), 5, 203-206
12. Inhibitors in Hemophilia A: What Patients and Families Need to Know
    By Jonathan Bernstein, M.D. Las Vegas, NV
    Louis M. Aledort, M.D. NY, NY
    Rebecca Berkowitz, R.N. Las Vegas, NV
13. Management of Inhibitors in Patients with Hemophilia A: Information for Healthcare Professionals
    By Wing Yen Wong, M.D. Los Angeles,CA
    Louis M. Aledort, M.D. NY, NY

The Following Medical Journal Articles Are From Haematologica/Journal of Hematology; Vol. 88, May 2003

The Factor VIII/vonWillebrand Factor Complex: Basic and Clinical Issues
by Augusto B. Federici
Angelo Bianchi Bonomi Hemophilia Thrombosis Center, IRCCS MaggioreHospital and University of Milan, Italy

Variation in Factor VIII Inhibitor Reactivity With Different Commercial Factor VIII Preparations: Is It of Clinical Importance?
by Erik Berntorp
Satellite Symposium at the Congress of the World Federation of Hemophilia, Seville, Spain, May 19-24, 2002

Epidemiology of Inhibitors and Current Treatment Strategies
by Wolfhart Kreuz, Carmen Escuriola Ettingshausen, Gunter Auerswald, Inmaculada Martinez Saguer, Sabine Becker, Markus Funk, Christine Heller, Dieter Klarmann, Thomas Klingebiel and the GTH PUP Study Group
Satellite Symposium at the XXV Congress of the World Federation of Hemophilia, Seville, Spain, May 19-24, 2002

The Role of Plasma-Derived Factor VIII /vonWillebrand Factor Concentrates in the Treatment of Hemophilia A Patients
by Gunter Auerswald, Torsten Spranger, and
Hans-Hermann Brackmann
Satellite Symposium at the XXV Congress of the World Federation of Hemophilia, Seville, Spain, May 19-24, 2002

Letter of Indication, Rituxan® (Rituximab)
Genentech, BiorGen IDEC, Medical Communication Department, April 10, 2006

Panel Discussion Following Journal Articles answered by:
Gunter Auerswald, Erik Berntorp, Wolfhart Kreuz, and Augusto B. Federici

Product Information

1. Alphanate®: Antihemophilic Factor (Human) has been developed by Grifols
   Product Monograph/Brochure & Package Insert Available

2. NovoSeven® (recombinant activated clotting factor VII rFVIIa) has been developed by Novo Nordisk
   Product Monograph/Brochure & Package Insert Available

3. FEIBA® (anti-Inhibitor Coagulant Complex) has been developed by Baxter Healthcare Corporation
   Product Monograph/Brochure & Package Insert Available